TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
NKTX

Nkarta Inc

Healthcare · Biotechnology

2.80$ -3.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NKTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
85.7% 77.4% 94.4% 89.7% 76.3% 66.8% 54.5% 69.9%
81.9% 42.6% 28.6% 22.2% 7.9% 8.2% 5.6% 9.8%
81.9% 76.4% 93.3% 86.9% 74.5% 65.5% 53.3% 68.4%
1.6% – – – 0.3% 0.1% 0.0% 0.5%
1.2% – – – -0.9% – – –
13.4% 21.1% 5.3% 4.7% 13.1% – – –
156.2% 152.6% 4.9% 8.4% 21.3% 27.9% 18.6% 22.7%
21.6% 17.0% 2.6% 4.7% 4.7% 6.2% 3.8% 5.5%
– 3.1% 0.4% 0.9% 0.9% 1.6% 1.2% 1.7%
3.8% 3.9% 0.3% 0.4% 0.4% 1.0% 0.1% 0.5%
-56.2% -52.6% 95.1% 91.6% 78.7% 72.1% 81.4% 77.3%
-58.1% -55.1% -35.0% -74.5% -67.2% -114.9% -108.6% -160.4%
523.4% 18.6% 9.4% 12.0% 9.2% 12.9% 13.5% 18.3%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?